Abstract
Guidelines have been compiled by The Joint Tuberculosis Committee of the British Thoracic Society to quantify the risks of reactivation of tuberculosis with anti-tumour necrosis factor alpha (anti-TNF-alpha) treatment. These guidelines are intended to inform respiratory physicians, gastroenterologists, rheumatologists and dermatologists, together with specialist nurses in those disciplines.
Publication types
-
Guideline
-
Practice Guideline
-
Review
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Algorithms
-
Antitubercular Agents / adverse effects
-
Chemical and Drug Induced Liver Injury / etiology
-
Child
-
Child, Preschool
-
Humans
-
Infant
-
Infant, Newborn
-
Middle Aged
-
Mycobacterium tuberculosis*
-
Risk Factors
-
Tuberculosis / drug therapy*
-
Tumor Necrosis Factor-alpha / therapeutic use*
Substances
-
Antitubercular Agents
-
Tumor Necrosis Factor-alpha